COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,745 Articles (22,502 medRxiv, 8,243 bioRxiv)

Most recent first Previous |  Page 2902: Articles 29011-29020  | Next

The effect of Arbidol Hydrochloride on reducing mortality of Covid-19 patients: a retrospective study of real world date from three hospitals in Wuhan
Liu, Q., Fang, X., Tian, L., Chen, X., Chung, U., Wang, K., Li, D., Dai, X., Zhu, Q., Xu, F., Shen, L., Wang, B., Yao, L., Peng, P.
10.1101/2020.04.11.20056523 — Posted: 2020-04-17 Discussion: Onsite
Long-term Co-existence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) with Antibody Response in Non-severe Coronavirus Disease 2019 (COVID-19) Patients
Wang, B., Wang, L., Kong, X., Geng, J., Xiao, D., Ma, C., Jiang, X., Wang, P.-H.
10.1101/2020.04.13.20040980 — Posted: 2020-04-17 Discussion: Onsite
Improving Coronavirus (COVID-19) Diagnosis using Deep Transfer Learning
Razzak, I., Naz, S., Rehman, A., Khan, A., Zaib, A.
10.1101/2020.04.11.20054643 — Posted: 2020-04-17
Time course quantitative detection of SARS-CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases
Wurtzer, S., Marechal, V., Mouchel, J.-M., Moulin, L.
10.1101/2020.04.12.20062679 — Posted: 2020-04-17 Discussion: Onsite
Shotgun proteomics of SARS-CoV-2 infected cells and its application to the optimisation of whole viral particle antigen production for vaccines
Grenga, L., Gallais, F., Pible, O., Gaillard, J.-C., Gouveia, D., Batina, H., Bazaline, N., Ruat, S., Culotta, K., Miotello, G., Debroas, S., Roncato, M.-A., Steinmetz, G., Foissard, C., Desplan, A., Alpha-Bazin, B., Almunia, C., Gas, F., Bellanger, L., Armengaud, J.
10.1101/2020.04.17.046193 — Posted: 2020-04-17 Discussion: Offsite
A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals
Riva, L., Yuan, S., Yin, X., Martin-Sancho, L., Matsunaga, N., Burgstaller, S., Pache, L., De Jesus, P., Hull, M. V., Chang, M., Chan, J. F. W., Cao, J., Kwok-Man Poon, V., Herbert, K., Nguyen, T.-T., Pu, Y., Nguyen, C., Rubanov, A., Martinez-Sobrido, L., Lui, W.-C., Miorin, L., White, K., Johnson, J. R., Benner, C., Sun, R., Schultz, P., Su, A. I., Garcia-Sastre, A., Chatterjee, A., Yuen, K.-Y., Chanda, S.
10.1101/2020.04.16.044016 — Posted: 2020-04-17 Discussion: Onsite
SARS-CoV-2 is transmitted via contact and via the air between ferrets.
Richard, M., Kok, A., de Meulder, D., Bestebroer, T. M., Lamers, M. M., Okba, N. M. A., Fentener van Vlissingen, M., Rockx, B., Haagmans, B. L., Koopmans, M. P. G., Fouchier, R. A. M., Herfst, S.
10.1101/2020.04.16.044503 — Posted: 2020-04-17 Discussion: Onsite
Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells
Han, G., Sinjab, A., Treekitkarnmongkol, W., Brennan, P., Hara, K., Chang, K., Bogatenkova, E., Sanchez-Espiridion, B., Behrens, C., Gao, B., Girard, L., Zhang, J., Sepesi, B., Cascone, T., Byers, L., Gibbons, D. L., Chen, J., Moghaddam, S. J., Ostrin, E. J., Fujimoto, J., Shay, J., Heymach, J. V., Minna, J. D., Dubinett, S., Scheet, P. A., Wistuba, I. I., Hill, E., Telesco, S., Stevenson, C., Spira, A. E., Wang, L., Kadara, H.
10.1101/2020.04.16.045617 — Posted: 2020-04-17
Revealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomes
Cirulli, E. T., Riffle, S., Bolze, A., Washington, N. L.
10.1101/2020.04.07.030544 — Posted: 2020-04-17 Discussion: Onsite
Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Plasma using a Coronavirus Antigen Microarray
de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Felgner, J., Obiero, J. M., Adenaiye, O. O., Tai, S., Hong, F. H., Norris, P., Stone, M., Simmons, G., Bagri, A., Schreiber, M., Buser, A., Holbro, A., Battegay, M., Milton, D. K., Prometheus Study Group, , Davies, H., Corash, L. M., Busch, M. P., Felgner, P. L., Khan, S.
10.1101/2020.04.15.043364 — Posted: 2020-04-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).